The US FDA Acts To Bolster Adverse Event Reporting For Compounded Drugs

 
• By Joanne S. Eglovitch
Clipboard with medical form and sign Hormone Replacement Therapy. - Image
FDA Wants Drug Compounding Pharmacies To Up Their Adverse Reporting Game • Source: Shutterstock

More from Manufacturing

More from Compliance